|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 5 (September 1), 1999:
pp. 1711-1716
I B Kinase Complex Is an Intracellular Target for Endotoxic
Lipopolysaccharide in Human Monocytic Cells
By
Jacek Hawiger,
Ruth Ann Veach,
Xue-Yan Liu,
Sheila Timmons, and
Dean W. Ballard
From the Department of Microbiology and Immunology and Howard Hughes
Medical Institute, Vanderbilt University Medical Center, Nashville, TN.
 |
ABSTRACT |
Endotoxic lipopolysaccharide (LPS) is a proinflammatory agonist
produced by gram-negative bacteria and a contributor to the majority of
the 400,000 septic shock cases recorded annually in US hospitals. The
primary target cells for LPS are monocytes and macrophages. Their
response consists of massive production of proinflammatory cytokines,
reactive oxygen- and nitrogen-intermediates, procoagulants, and cell
adhesion molecules. In turn, expression of these LPS-responsive factors
contributes to collapse of the circulatory system, to disseminated
intravascular coagulation, and to a 30% mortality rate. A common
intracellular mechanism responsible for the expression of septic shock
genes in monocytes and macrophages involves the activation of NF- B.
This transcription factor is regulated by a family of structurally
related inhibitors including I B , I B , and I B , which
trap NF- B in the cytoplasm. In this report, the investigators show
that LPS derived from different gram-negative bacteria activates
cytokine-responsive I B kinases containing catalytic subunits termed
IKK (IKK1) and IKK (IKK2). The kinetics of IKK and IKK
activation in LPS-stimulated human monocytic cells differ from that
recorded on their stimulation with tumor necrosis factor- , thereby
implying a distinct activation mechanism. LPS-activated IKK complexes
phosphorylate all 3 inhibitors of NF- B: I B , I B , and
I B . Moreover, LPS activates IKK preferentially, relative to
IKK . Thus, IKK complex constitutes the main intracellular target for
LPS-induced NF- B signaling to the nucleus in human monocytic cells
to activate genes responsible for septic shock.
© 1999 by The American Society of Hematology.
 |
INTRODUCTION |
PROINFLAMMATORY STIMULI signal to the
nucleus via transcription factor NF- B, which activates a set of
genes responsive to inflammatory, immune, and oxidant stress. These
stimuli encompass biologic agents such as endotoxic lipopolysaccharide
(LPS) and bacterial superantigens (eg, toxic shock syndrome toxin and
streptococcal pyrogenic exotoxin), which are responsible for the
majority of septic shock cases. In addition, intracellular bacteria
(eg, Mycobacterium tuberculosis), viruses (eg, human
immunodeficiency virus, human T-cell lymphotropic virus, and
cytomegalovirus), cytokines (tumor necrosis factor- [TNF- ],
interlukin-1 [IL-1]), and lipid peroxides induce nuclear import of
NF- B.1-3 In response to these agents, the cytoplasmic
ankyrin motif-rich inhibitors of NF- B, I B , I B , and
I B are phosphorylated, ubiquitinated, and then degraded by
adenosine triphosphate (ATP)-dependent 26S proteosomes.4-9 Thus, phosphorylation-dependent proteolysis of I B proteins releases NF- B for subsequent import to the nucleus. In turn, NF- B
stimulates transcription of a number of genes containing cognate B
sites in their enhancer/promoter regions. These NF- B-responsive
genes encode cytokines (TNF- , IL-1, IL-6, IL-8, and IL-12),
procoagulant molecules (tissue factor and plasminogen activator
inhibitor 1), signal transducers (inducible nitric oxide synthase and
cyclooxygenase 2), cell adhesion molecules (endothelial selectin,
intracellular cell adhesion molecule-1, and vascular cell adhesion
molecule-1), and growth factors (granulocyte-colony-stimulating
factor).3,6,10 The products of these NF- B-regulated
genes expressed in monocytes, macrophages, and vascular endothelial
cells contribute to the development of septic shock and disseminated
intravascular coagulation, leading to multiple organ failure and
death.1,3 These findings highlight NF- B as a major
intracellular mediator of the systemic inflammatory response syndrome
known as sepsis and septic shock.11
The fact that multiple proinflammatory stimuli, LPS, TNF- , and IL-1,
involved in induction and mediation of septic shock syndrome, evoke
activation of NF- B indicates that the signals generated by these
stimuli and their cognate receptors converge at the common step of
NF- B activation.6 This step appears to be specific
phosphorylation of inhibitory proteins, such as I B, by their
kinase(s). A primary target for I B kinases is I B . This
inhibitor is characterized by a signal response domain in the
amino-terminal segment, ankyrin repeats in the midsection, and a
PEST domain in the carboxyl terminal
segment.12 The signal response domain contains two serines
at positions 32 and 36, which are targeted for specific phosphorylation
by I B kinases.5,13 The PEST domain bears serines
phosphorylated by casein kinase II involved in constitutive turnover of
I B .14
The I B kinase that catalyzes inducible phosphorylation of serines
32 and 36 in response to cytokines was initially reported by Chen et
al15 as part of a 700-kD complex requiring ubiquitin for
full activity. Subsequently, two serine/threonine kinases termed I B
kinase (IKK or IKK1) and I B kinase (IKK or IKK2) of
molecular weight 85 kD and 87 kD, respectively, were
identified.16-19 Both of these kinases are homologous to a
previously reported conserved helix-loop-helix ubiquitous kinase with a
unique structure containing a kinase domain linked to a leucine zipper
domain and a helix-loop-helix domain. Both IKK and IKK
phosphorylate serines 32 and 36 in I B , suggesting functional
homology as well.19
Although it is well known that primary target cells for LPS are
monocytes and macrophages,3,20 the mechanism by which LPS
induces NF- B in this cellular setting remained unknown. Therefore, we hypothesized that the recently discovered I B kinases constitute an intracellular target for LPS. Our results provide evidence that
I B kinase in human monocytic THP-1 cells is targeted by LPS, thereby assigning this multiunit kinase complex a primary role as
the signal transducer responsible for NF- B mobilization in response
to septic-shock inducers.
 |
MATERIALS AND METHODS |
Reagents.
Rabbit polyclonal antibodies were generated by immunizing rabbits with
synthetic peptides corresponding to amino acids 1-28 (NH2-terminal peptide) and 731-744 (COOH-terminal peptide)
of human IKK and a synthetic peptide corresponding to amino acids 743-756 of human IKK . The peptides were covalently coupled to keyhole limpet hemocyanin before injection together with complete Freund adjuvant. The antibody lgG fraction of each antiserum was purified by absorption to and elution from Protein A Sepharose (Zymed,
San Francisco, CA). I B -specific (amino acids 289-317) antipeptide
rabbit antibodies were prepared as described previously.9 Glutathione S-transferase (GST)-I B (1-54), I B (1-44), and I B (1-61) fusion proteins (wild type and I B mutant S32A and S36A) were prepared as described.17,19,21
LPS preparations were derived from: (1) Escherichia coli
0127:B8 (extracted by Boivin method; DIFCO, Detroit, MI), (2) E
coli 0127:B8 (prepared by phenol extraction and gel filtration
chromatography), (3) Pseudomonas aeruginosa serotype 10 (chromatographically purified by gel filtration), and (4)
Salmonella minnesota (prepared by phenol extraction and gel
filtration chromatography). The latter three LPS preparations were
obtained from Sigma Chemical Company (St. Louis, MO).
Cell culture.
Human monocytic THP-1 cells were cultured in RPMI 1640 medium
supplemented with 10% fetal bovine serum containing no detectable LPS
(<0.006 ng/mL in Limulus Amebocyte Gel Clot as determined by the
manufacturer, Atlanta Biologicals, Norcross, GA), 2 mmol/L L-glutamine,
and antibiotics as described.4 Where indicated, 5 mL of
THP-1 cells (106/mL) were stimulated with E
coli LPS O127:B8 (DIFCO) or TNF- with the potency of 32,000 U per µg (Mallinckrodt, St Louis, MO) at concentrations
and times specified in the text.
Immunoprecipitation and immunoblotting.
Cytoplasmic extracts were prepared from THP-1 cells by detergent lysis
(0.1 % Nonidet P40 in 10 mmol/L HEPES, pH 7.9, 10 mmol/L KCl, 1.5 mmol/L MgCl2, 300 mmol/L sucrose) in
the presence of phosphatase inhibitors (12.5 mmol/L
-glycerophosphate, 2 mmol/L NaF, 100 µmol/L
Na3VO4) and protease inhibitors (0.1 mmol/L
EDTA, 0.1 mmol/L EGTA, 1 mg/mL pefabloc SC, 50 µg/mL
antipain, 1 mg/mL aprotinin, 20 µg/mL chymostatin, 5 µg/mL E64, 1 µg/mL leupeptin, 1 µg/mL pepstatin, and 20 µg/mL phosphoramidon).
Lysates were adjusted to a final concentration of 50 mmol/L HEPES (pH
7), 250 mmol/L NaCl, and 5 mmol/L EDTA before addition of specific
IKK or IKK antibody IgG (20 µg added to reaction mixture).
Specific I B antipeptide antibody was used as described
previously.9
Immunoprecipitations were typically performed in 400 µL reaction
mixtures containing 100 to 500 µg of total cytoplasmic protein and 10 µL of protein A-Sepharose beads (Zymed). In some immunoprecipitation experiments, protein A-Sepharose beads were precoated with specific antibodies and washed once with ELB buffer (50 mmol/L
HEPES, 250 mmol/L NaCl, 5 mmol/L EDTA, and 0.1% Nonidet
P-40).5 Immunoprecipitates were washed three times with ELB
buffer in the presence of phosphatase inhibitors, resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and
transferred to polyvinylidine difluoride membranes. Immunoreactive
polypeptides were detected with anti-IKK antibodies and an enhanced
chemiluminescence system (Amersham Pharmacia Biotech,
Piscataway, NJ).
IKK assay.
I B kinase activity in immunoprecipitates obtained with anti-IKK
and anti-IKK antibodies in cytoplasmic lysate of THP-1 cells was
measured as described previously.17, 22 Briefly,
cytoplasmic extracts from 5 × 106 THP-1 cells were
prepared and immunoprecipitated as described above. They were
immunoprecipitated with anti-IKK antibody IgG (10 µg added to 100 to 500 µg of total protein), unless specified otherwise.
Immunoprecipitates were washed thrice with ELB buffer and once with
kinase buffer (10 mmol/L HEPES pH 7.4, 1 mmol/L MnCl2, 5 mmol/L MgCl2, 12.5 mmol/L -glycerophosphate, 50 µmol/L Na3VO4, 2 mmol/L NaF, 0.5 mmol/L
dithiothrietol, and 10 µmol/L ATP). Immunoprecipitates were
resuspended in kinase buffer (20 µL) containing 1 µg I B
(residues 1-54), GST fusion protein, and 5µCi of
32P- -ATP (ICN cat no. 38101x, 4,500 Ci/mmol). The kinase
reaction was done at 30°C for 30 minutes and was stopped by
addition of Laemmli buffer containing 2.5% -mercaptoethanol. After
a 5-minute incubation at 100°C, the mixture was spun down and the
supernatant applied to SDS-PAGE (10%). Dried gels were applied to
Biomax film (Eastman Kodak, Rochester, NY). In some
experiments, dried gels were analyzed in Fuji FLA 2000 Fluorescent Image Analyzer (Fuji Medical Systems, Stamford, CT).
Electrophoretic mobility shift assay (EMSA).
To measure the nuclear import of NF- B in THP-1 cells, EMSA was
performed as described with a radiolabeled B probe.4,9
 |
RESULTS |
Expression of endogenous IKK and IKK in human monocytic THP-1
cells.
At least 2 kinases specific for I B and I B were recently
identified in Hela and 293 EBNA cells and named IKK and
IKK .16-19 To monitor their expression in human monocytic
cells, we prepared rabbit polyclonal antibodies directed against
peptides derived from the NH2-terminal segment (residues
1-28) and the COOH-terminal segment (residues 731-744) of IKK and
the COOH-terminal segment of IKK (residues 743-756). The antibodies
were monospecific for homologous peptides in an enzyme-linked
immunosorbent assay using peptide-coated wells (results not shown).
When cytoplasmic extracts from monocytic THP-1 cells were
immunoprecipitated and then probed with these antibodies by
immunoblotting, 2 bands of 85 kD and 87 kD, apparent molecular weights,
were discerned with anti-IKK antibody
(Fig 1A, lane 1). In contrast, anti-IKK
antibody precipitated and reacted in immunoblotting with the 87-kD band
representing IKK (Fig 1B, lane 2). Thus, the anti-IKK antibody
was monospecific for IKK and did not cross-react with IKK (Fig
1B, lane 1). These bands were not visualized when antibodies were
preincubated with homologous peptides before the immunoblotting
(results not shown).

View larger version (75K):
[in this window]
[in a new window]
| Fig 1.
Detection of IKK and IKK in human monocytic THP-1
cells by immunoprecipitation and immunoblotting. Cytoplasmic lysates
from unstimulated cells were immunoprecipitated with anti-IKK
NH2-terminal peptide antibody (lane 1) and anti-IKK
COOH-terminal peptide antibody (lane 2). Immunoprecipitated proteins
were resolved by (A) SDS-PAGE and immunoblotted with anti-IKK
NH2-terminal peptide antibody, with (B) anti-IKK
COOH-terminal peptide antibody (NS represents nonspecific band).
|
|
Stimulus-dependent activation of IKK and IKK in human monocytic
THP-1 cells.
Having established the presence of IKK and IKK in the cytoplasmic
fraction of human monocytic THP-1 cells, we examined the kinase
activity in immunoprecipitates obtained from LPS-stimulated cells as
compared with those from TNF- -stimulated cells
(Fig 2A). Stimulated and nonstimulated
THP-1 cells were lysed, and the cytoplasmic fraction was prepared by
differential centrifugation. Immunoprecipitated IKK and IKK were
assayed for kinase activity with 32P- -ATP and a fusion
protein made of I B residues 1-54 attached to
GST.17,22 Nonstimulated THP-1 cells had no detectable
kinase activity in immunoprecipitates obtained with anti-IKK
antibodies (Fig 2A, lane 1). Low-level basal kinase
activity was detectable in anti-IKK antibody immunoprecipitates (Fig
2A, lane 4). When cells were stimulated with LPS from E coli
0127:B8 (Difco) (1 µg/mL for 30 minutes), kinase activity was readily
detectable by phosphorylation of GST-I B (residues 1-54) fusion
protein in immunoprecipitates produced by 2 antibodies (Fig 2A, lanes 3 and 6). Phosphoimager analysis of these bands indicated that the
LPS-responsive kinase activity immunoprecipitated by monospecific anti-IKK antibody exceeds the activity precipitated by anti-IKK antibody. Similar, albeit weaker, kinase activity of immunoprecipitated IKK and IKK was evoked by TNF- (100 U/mL for 5 minutes) (Fig 2A, lanes 2 and 5). Kinase activity of immunoprecipitated IKK and
IKK was specific for serines 32 and 36 of I B because a fusion
protein containing mutant I B segment with serines 32 and 36 replaced by alanine was not phosphorylated (Fig 2B). Activation of
I B kinase complex containing IKK and IKK by LPS in THP-1 cells
was concentration dependent. At least 10 ng/mL of LPS from E
coli 0127:B8 (DIFCO, Detroit, MI) was sufficient to induce
detectable IKK and IKK activity (Fig
3). By comparison, the lowest concentration of TNF- inducing similar
activation was 30 U/mL or approximately 1 ng/mL. All preparations of
LPS tested induced activation of IKK and IKK . These included LPS
derived from E coli 0127:B8, P aeruginosa, and S
minnesota (Fig 4). The activation of
IKK and IKK by structurally diverse LPS from different
gram-negative bacterial species indicates that IKK complex responds to
all endotoxic LPS tested. However, the method of extraction of LPS
derived from the same E coli 0127:B8 serotype results in
different IKK complex activating potency of LPS (Fig 4, lanes 2 and 3).

View larger version (30K):
[in this window]
[in a new window]
| Fig 2.
Stimulus-dependent activation of IKK and IKK in
human monocytic THP-1 cells. (A) Nonstimulated cells (lanes 1, 4),
TNF- -stimulated (100 U/mL)(5 minutes) cells (lanes 2, 5), and LPS
E coli 0127:B8 (1 µg/mL)-stimulated (30 minutes) cells (lanes
3, 6). Lanes 1-3 represent immunoprecipitates obtained with anti-IKK
antibody; and lanes 4-6 represent immunoprecipitates obtained with anti
IKK antibody. The IKK kinase assay was done as described in
Materials and Methods by using I B -GST fusion protein as the
substrate. (B) IKK and IKK activity toward wild type I B
substrate and I B mutant (S32A and S36A) substrate prepared as GST
fusion proteins. The cells were stimulated with TNF- (100 U/mL) for
5 minutes and with LPS (1 µg/mL) for 30 minutes.
|
|

View larger version (28K):
[in this window]
[in a new window]
| Fig 3.
Concentration-dependent activation of IKK and IKK
by LPS and TNF- . Human monocytic THP-1 cells were stimulated with
increasing concentrations of LPS for 30 minutes or TNF- for 5 minutes and cytoplasmic lysates were prepared with anti-IKK
antibody. The IKK kinase assay was done as described in Materials and
Methods; the substrate was a fusion protein made of wild-type I B
(amino acids 1-54) and GST.
|
|

View larger version (28K):
[in this window]
[in a new window]
| Fig 4.
Activation of IKK and IKK in human monocytic THP-1
cells by LPS derived from different gram-negative bacteria. Lane 1, Unstimulated cells; Lane 2, LPS from E coli 0127:B8 extracted
by Boivin method (DIFCO); Lane 3, LPS from E coli 0127:B8
prepared by phenol extraction and gel filtration chromatography
(Sigma); Lane 4, LPS from P aeruginosa serotype 10. LPS from
S minnesota. Human monocytic THP-1 cells were stimulated with
different preparations of LPS at 1 µg/mL for 30 minutes and the IKK
kinase assay was done as specified in Materials and Methods.The kinase
complex was immunoprecipitated with anti-IKK antibody.
|
|
IKK and IKK are differentially activated by LPS and TNF- .
Stimulation of human monocytic THP-1 cells by LPS or TNF- was
followed by determination of enzymatic activity of IKK and IKK in
cytoplasmic extracts of stimulated cells prepared at different time
intervals. Three NF- B inhibitors, I B , I B , and I B , presented as GST fusion proteins were tested as phosphorylation substrates in standard in vitro kinase assays with immune complex containing IKK. LPS stimulation of THP-1 cells for 10 minutes was
sufficient to induce measurable kinase activity, which peaked at 30 minutes (Fig 5). The significant increase
in I B kinase activity at 10 minutes is consistent with
phosphorylation and degradation of I B in LPS-treated THP-1 cells
after 10 minutes stimulation as documented by immunoblotting with
specific I B antipeptide antibody. Concurrently, the nuclear
import of NF- B monitored by the electrophoretic mobility shift assay
shows progressive increase reaching maximum at 30 minutes
(Fig 6A and B). Significantly, all three
inhibitory proteins, I B , I B , and I B , used as GST fusion proteins at equivalent concentrations were phosphorylated with
similar kinetics in response to LPS. In contrast, TNF- stimulation of THP-1 cells resulted in much faster kinetics of phosphorylation of
I B -GST fusion protein reaching peak at 3 to 5 minutes and declining after 20 minutes (Fig 5). This pattern of rapid activation by
TNF- is consistent with much faster degradation of endogenous I B and nuclear import of NF- B reaching maximum at 10 minutes in TNF- -stimulated THP1 cells (Fig 6A and B). The 5 times lower concentration of TNF- (20 U/mL) did not change the rapid course of
IKK /IKK activation (results not shown). Thus, the differences in
activation kinetics of I B kinase complex induced by LPS and TNF-
suggest that these proinflammatory agonists evoke different signaling
pathways resulting in activation of IKK -containing and
IKK -containing complex in human monocytic cells.

View larger version (51K):
[in this window]
[in a new window]
| Fig 5.
Time course of LPS-induced activation of IKK and
IKK as compared with that induced by TNF- . (A) LPS-induced
phosphorylation of 1µg I B -GST, I B -GST, and I B -GST
fusion proteins; (B) TNF- -induced phosphorylation of I B -GST
fusion protein. The IKK kinase assay was done as specified in Materials
and Methods and the kinase complex was immunoprecipitated with
anti-IKK antibody.
|
|

View larger version (41K):
[in this window]
[in a new window]
| Fig 6.
Time course of LPS-induced degradation of I B and
nuclear import of NF- B. (A) Immunoblotting of I B in
nonstimulated (time 0) and TNF- -stimulated or LPS-stimulated THP-1
cells. (B) Electrophoretic mobility shift assay of NF- B in nuclear
fractions isolated from nonstimulated (time 0) and TNF- -stimulated
or LPS-stimulated THP-1 cells. LPS from E coli 0127:B8 was used
in concentration of 1 µg/mL and TNF- at 100 U/mL.
|
|
 |
DISCUSSION |
The results presented here have several important implications for the
cellular and molecular pathogenesis of septic shock induced by LPS.
First, our studies provide evidence that I B kinase complex
containing IKK and IKK is an intracellular target for LPS
produced by different gram-negative bacteria (enterobacteriaceae and nonenterobacteriaceae).
Second, IKK appears to be a more LPS-responsive signal transducer
than IKK based on observed kinase activity (Fig 2). This is
consistent with recent demonstration that IKK is not required for
signaling induced by proinflammatory cytokines, IL-1, or
TNF- .23-25 The lowest concentration of LPS that induces
detectable activation of IKK and IKK in human monocytic THP-1
cells was 10 ng/mL. Treatment of human peripheral blood mononuclear
cells ("adherent monocytes") with 100 ng/mL of E coli
0111:B4 lipopolysaccharide also induces IKK activity, thus validating
THP-1 cells as a model for studying LPS-induced IKK activation in human
cells of the myelomonocytic lineage.26 Moreover,
LPS-stimulated and TNF- -stimulated IKK complex can phosphorylate
not only inhibitory proteins I B and I B , but also I B .
The I B kinases provide a pivotal checkpoint in NF- B-mediated
signaling to the nucleus. Thus, activation of I B kinases by LPS in
human monocytic cells constitutes an important link in understanding
the NF- B recruitment in molecular pathogenesis of septic shock.
Whether continuing activation of I B kinases in vivo by LPS derived
from different gram-negative bacteria results in persistent nuclear
import of NF- B demonstrated in nonsurvivors of septic
shock11 remains to be established with in vivo models. Importantly, kinetics of phosphorylation of all three inhibitory proteins, I B , I B , and I B , as demonstrated herein by
IKK complex activated by LPS can contribute to progressive activation of the nuclear import of NF- B.
Third, the distinct activation kinetics of IKK -containing and
IKK -containing complex by LPS and TNF- in human monocytic cells
is consistent with different rate of the nuclear import of
NF- B in these cells (Fig 6).4,9,27 These agonists
signal through distinct receptors (toll-like receptor 2 and 4 v
TNF- receptor 1 and 2).28-31 Receptor-proximal steps
in intracellular signaling induced by TNF- that interacts with its
cognate receptor, TNFR1, and by LPS interacting with its cognate
receptor TLR2 differ.29 Whereas TNF- -induced signaling
requires TRAF2 in mammalian cell transfectants, LPS-induced signaling
via TLR2 seems to require TRAF6.29,32 The latter is
required for IL-1 induced signaling, which also uses an adaptor protein
MyD88.33-35 Dominant-negative mutants of MyD88 and TRAF6
expressed in TLR2- and IL-1R-transfected cells selectively blocked
signaling evoked by LPS and IL-1 but remained ineffective toward
TNF- -induced signaling.29,32 These differences in
receptor-proximal signaling may explain the different kinetics of IKK
complex activation by LPS and TNF- in human monocytic THP-1 cells
used in our experiments. Further dissection of LPS-stimulated and
TNF- -stimulated specific pathways of IKK complex activation will
help in the development of new inhibitors designed to interrupt potentially lethal lipopolysaccharide-induced intracellular mechanism of septic shock.
 |
ACKNOWLEDGMENT |
The authors thank Traci Tidwell, Susan Rowlinson, and Erica Holleran
for assistance in preparation of the manuscript, Zhi-Liang Chu and Min
Dai for preparation of GST fusion proteins, and Hiroyasu Nakano,
Juntendo University School of Medicine, Tokyo, Japan, for plasmid
pGEX-4T-I B (1-61).
 |
FOOTNOTES |
Submitted December 31, 1998; accepted May 5, 1999.
Supported in part by the National Institutes of Health, Grant Nos.
R37HL30647, HL45994, and AI33839.
The publication costs of this
article were defrayed in part by
page charge payment. This article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. section
1734 solely to indicate this fact.
Address reprint requests to Jacek Hawiger, MD, PhD, Department of
Microbiology & Immunology, Vanderbilt University School of Medicine,
A-5321 MCN, 1161 21st Ave South, Nashville, TN 37232-2363; e-mail:
jacek.hawiger{at}mcmail.vanderbilt.edu.
 |
REFERENCES |
1.
Bone RC:
The pathogenesis of sepsis.
Ann Intern Med
115:457, 1991
2.
Wenzel RP, Pinsky MR, Ulevitch RJ, Young L:
Current understanding of sepsis.
Clin Infect Dis
22:407, 1996[Medline]
[Order article via Infotrieve]
3.
Hawiger J:
Lipopolysaccharide-induced signal transduction and gene transcription, in
Brigham KL
(ed):
Endotoxin and the Lungs, vol 77. New York, NY, Marcel Dekker, 1994, p 69.
4.
Cordle SR, Donald R, Read MA, Hawiger J:
Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.
J Biol Chem
268:11803, 1993[Abstract/Free Full Text]
5.
Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW:
Coupling of a signal response domain in I B to multiple pathways for NF- B activation.
Mol Cell Biol
15:2809, 1995[Abstract]
6.
Ghosh S, May MJ, Kopp EB:
NF- B and rel proteins: Evolutionarily conserved mediators of immune responses.
Annu Rev Immun
16:225, 1998[Medline]
[Order article via Infotrieve]
7.
Whiteside ST, Epinat JC, Rice NR, Israel A:
I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
EMBO J
16:1413, 1997[Medline]
[Order article via Infotrieve]
8.
Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW:
Signal-induced degradation of I B requires site-specific ubiquitination.
Proc Natl Acad Sci USA
92:11259, 1995[Abstract/Free Full Text]
9.
Donald R, Ballard DW, Hawiger J:
Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators.
J Biol Chem
270:9, 1995[Abstract/Free Full Text]
10.
Mackman N:
Regulation of the tissue factor gene.
FASEB J
9:883, 1995[Abstract]
11.
Bohrer H, Qui F, Zimmerman T, Zhang Y, Jllmer T, Mannel D, Bottiger BW, Stern DM, Waldherr R, Saeger H-D, Ziegler R, Bierhaus A, Martin E, Nawroth PP:
Role of NF- B in the mortality of sepsis.
J Clin Invest
100:972, 1997[Medline]
[Order article via Infotrieve]
12.
Baldwin AS:
The NF- B and I- B proteins: New discoveries and insights.
Annu Rev Immunol
14:649, 1996[Medline]
[Order article via Infotrieve]
13.
Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U:
Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation.
Science
267:1485, 1995[Abstract/Free Full Text]
14.
Barroga CF, Stevenson JK, Schwartz EM, Verma I:
Constitutive phosphorylation of I B by casein kinase II.
Proc Natl Acad Sci USA
92:7637, 1995[Abstract/Free Full Text]
15.
Chen ZJ, Parent L, Maniatis T:
Site-specific phosphorylation of I B by a novel ubiquitination-dependent protein kinase activity.
Cell
84:853, 1996[Medline]
[Order article via Infotrieve]
16.
Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M:
Identification and characterization of an I B kinase.
Cell
90:373, 1997[Medline]
[Order article via Infotrieve]
17.
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M:
A cytokine-responsive I B kinase that activates the transcription factor NF- B.
Nature
388:548, 1997[Medline]
[Order article via Infotrieve]
18.
Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M:
The I B kinase complex (IKK) contains two kinase subunits, IKK and IKK , necessary for I B phosphorylation and NF- B activation.
Cell
91:243, 1997[Medline]
[Order article via Infotrieve]
19.
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li JW, Young DB, Barbosa M, Mann M:
IKK-1 and IKK-2: Cytokine-activated I B kinases essential for NF- B activation.
Science
278:860, 1997[Abstract/Free Full Text]
20.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC:
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Science
249:1431, 1990[Abstract/Free Full Text]
21.
Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, Okumura K:
Differential regualtion of I B kinase and by two upstream kinases, NF- B-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1.
Proc Natl Acad Sci USA
95:3537, 1998[Abstract/Free Full Text]
22.
Chu Z-L, DiDonato JA, Hawiger J, Ballard DW:
The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates I B kinases containing IKK and IKK .
J Biol Chem
273:15891, 1998[Abstract/Free Full Text]
23.
Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, Karin M:
Abnormal morphogenesis but intact IKK activation in mice lacking the IKK subunit of I B kinase.
Science
284:316, 1999[Abstract/Free Full Text]
24.
Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, Sanjo H, Yoshikawa K, Terada N, Akira N:
Limb and skin abnormalities in mice lacking IKK.
Science
284:313, 1999[Abstract/Free Full Text]
25.
Delhase M, Hayakawa M, Chen Y, Karin M:
Positive and negative regulation of I B kinase activity through IKK subunit phosphorylation.
Science
284:309, 1999[Abstract/Free Full Text]
26.
O'Connell MA, Bennett BL, Mercurio F, Manning AM, Mackman N:
Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells.
J Biol Chem
273:30410, 1998[Abstract/Free Full Text]
27.
Hohmann HP, Roland R, Scheidereit C, Van Loon APGM:
Maintenance of NF- B activity is dependent on protein synthesis and the continuous presence of external stimuli.
Mol Cell Biol
11:259, 1991[Abstract/Free Full Text]
28.
Yang R-B, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ:
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling.
Nature
395:284, 1998[Medline]
[Order article via Infotrieve]
29.
Kirschning CJ, Wesche H, Ayres TM:
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.
J Exp Med
188:2091, 1998[Abstract/Free Full Text]
30.
Poltorak A, Xialong H, Smirnova I, Liu M, Huggel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B:
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 gene.
Science
282:2085, 1998[Abstract/Free Full Text]
31.
Liu Z, Hsu H, Goeddel DV, Karin M:
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF- B activation prevents cell death.
Cell
87:565, 1996[Medline]
[Order article via Infotrieve]
32.
Zhang F, Kirschning C, Mancinelli R, Xu X, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M:
Bacterial lipopolysaccharide activates nuclear factor-B through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.
J Biol Chem
274:7611, 1999[Abstract/Free Full Text]
33.
Wesche H, Henzel W, Shillinglaw W, Li S, Cao Z:
MyD88: An adapter that recruits IRAK to the IL-1 receptor complex 7.
Immunity
7:837, 1997[Medline]
[Order article via Infotrieve]
34.
Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway C:
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
Mol Cell
2:253, 1998[Medline]
[Order article via Infotrieve]
35.
Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer J, Marco F, French L, Tschopp J:
MyD88, an adapter protein involved in interleukin-1 signaling.
J Biol Chem
273:12203, 1998[Abstract/Free Full Text]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Janic, T. M. Umstead, D. S. Phelps, and J. Floros
Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation
Am J Physiol Lung Cell Mol Physiol,
February 1, 2005;
288(2):
L317 - L325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Syrovets, B. Buchele, C. Krauss, Y. Laumonnier, and T. Simmet
Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-{alpha} Induction in Monocytes by Direct Interaction with I{kappa}B Kinases
J. Immunol.,
January 1, 2005;
174(1):
498 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xiong, H. Li, Y. Chen, J. Zhao, and J. C. Unkeless
Interaction of TRAF6 with MAST205 Regulates NF-{kappa}B Activation and MAST205 Stability
J. Biol. Chem.,
October 15, 2004;
279(42):
43675 - 43683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sun, F. Li, J. Chen, and J. Xu
Effect of Ketamine on NF-kappa B Activity and TNF-alpha Production in Endotoxin-Treated Rats
Ann. Clin. Lab. Sci.,
April 1, 2004;
34(2):
181 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Henriksen, M. Hitt, Z. Xing, J. Wang, C. Haslett, R. A. Riemersma, D. J. Webb, Y. V. Kotelevtsev, and J.-M. Sallenave
Adenoviral Gene Delivery of Elafin and Secretory Leukocyte Protease Inhibitor Attenuates NF-{kappa}B-Dependent Inflammatory Responses of Human Endothelial Cells and Macrophages to Atherogenic Stimuli
J. Immunol.,
April 1, 2004;
172(7):
4535 - 4544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takada and B. B. Aggarwal
Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Sensitizes Macrophages to Lipopolysaccharide-induced Nuclear Factor-{kappa}B, Mitogen-activated Protein Kinases, and Apoptosis
J. Biol. Chem.,
June 20, 2003;
278(26):
23390 - 23397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Pingle, J. F. Sanchez, D. M. Hallam, A. L. Williamson, S. B. Maggirwar, and V. Ramkumar
Hypertonicity Inhibits Lipopolysaccharide-Induced Nitric Oxide Synthase Expression in Smooth Muscle Cells by Inhibiting Nuclear Factor {kappa}B
Mol. Pharmacol.,
June 1, 2003;
63(6):
1238 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Carter, K. N. Pennington, B. J. Ungurait, and D. W. Ballard
In Vivo Identification of Inducible Phosphoacceptors in the IKK{gamma}/NEMO Subunit of Human I{kappa}B Kinase
J. Biol. Chem.,
May 23, 2003;
278(22):
19642 - 19648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog
VEGF expression in human macrophages is NF-{kappa}B-dependent: studies using adenoviruses expressing the endogenous NF-{kappa}B inhibitor I{kappa}B{alpha} and a kinase-defective form of the I{kappa}B kinase 2
J. Cell Sci.,
February 15, 2003;
116(4):
665 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.M. Monick and G.W. Hunninghake
Activation of second messenger pathways in alveolar macrophages by endotoxin
Eur. Respir. J.,
July 1, 2002;
20(1):
210 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Silverman and T. Maniatis
NF-{kappa}B signaling pathways in mammalian and insect innate immunity
Genes & Dev.,
September 15, 2001;
15(18):
2321 - 2342.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Saha, R. S. Barua, M. E. Astiz, E. C. Rackow, and L-J. Eales-Reynolds
Monophosphoryl lipid A stimulated up-regulation of reactive oxygen intermediates in human monocytes in vitro
J. Leukoc. Biol.,
September 1, 2001;
70(3):
381 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Syrovets, M. Jendrach, A. Rohwedder, A. Schule, and T. Simmet
Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK{beta}-mediated NF-{kappa}B activation
Blood,
June 15, 2001;
97(12):
3941 - 3950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alexander and E. Th. Rietschel
Invited review: Bacterial lipopolysaccharides and innate immunity
Innate Immunity,
June 1, 2001;
7(3):
167 - 202.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Purcell, C. Yu, D. He, J. Xiang, N. Paran, J. A. DiDonato, S. Yamaoka, Y. Shaul, and A. Lin
Activation of NF-{kappa}B by hepatitis B virus X protein through an I{kappa}B kinase-independent mechanism
Am J Physiol Gastrointest Liver Physiol,
April 1, 2001;
280(4):
G669 - G677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ruckdeschel, O. Mannel, K. Richter, C. A. Jacobi, K. Trulzsch, B. Rouot, and J. Heesemann
Yersinia Outer Protein P of Yersinia enterocolitica Simultaneously Blocks the Nuclear Factor-{{kappa}}B Pathway and Exploits Lipopolysaccharide Signaling to Trigger Apoptosis in Macrophages
J. Immunol.,
February 1, 2001;
166(3):
1823 - 1831.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|